These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 23442563)

  • 1. Characteristics and follow-up of newly managed HIV-infected patients in the national referral center in Ouagadougou, Burkina Faso.
    Tiéno H; Guira O; Sagna Y; Diendéré EA; Diallo I; Bognounou R; Zoungrana L; Zida S; Nikiéma P; Drabo YJ
    J Int Assoc Provid AIDS Care; 2015; 14(1):40-5. PubMed ID: 23442563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Factors for Early Mortality on Antiretroviral Treatment of Elderly People Infected with HIV in Burkina Faso.
    Ouédraogo DD; Sawadogo LM; Sagna Y; Sawadogo AB; Diallo I; Hema A; Poda A; Drabo YJ
    J Int Assoc Provid AIDS Care; 2015; 14(6):553-9. PubMed ID: 25294855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rheumatic disorders observed in HIV infected patients undergoing highly active antiretroviral therapy (HAART): a 366 case prospective study in Burkina Faso].
    Ouédraogo DD; Lompo CP; Tiéno H; Bognounou R; Diendéré AE; Sawadogo A; Zoungrana L; Drabo JY
    Med Trop (Mars); 2010 Aug; 70(4):345-8. PubMed ID: 22368930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and factors associated with the clinical forms of lipoatrophy during highly active antiretroviral therapy in Ouagadougou, Burkina Faso.
    Guira O; Tiéno H; Yaméogo B; Diendéré AE; Korsaga N; Sagna Y; Zoungrana L; Diallo I; Traoré R; Drabo JY
    J Int Assoc Provid AIDS Care; 2014; 13(2):184-7. PubMed ID: 24114724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Metabolic disorders and cardiovascular risk factors observed in patients infected by the HIV with antiretroviral therapy in Burkina Faso].
    Bognounou R; Diendéré A; Diallo I; Tieno H; Guira O; Ouedraogo DD; Drabo YJ
    Med Trop (Mars); 2011 Dec; 71(6):626-7. PubMed ID: 22393637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Laboratory test features of newly diagnosed adult HIV-infected patients in Ouagadougou (Burkina Faso)].
    Sagna Y; Koulidiaty J; Diallo I; Sanou AF; Bagbila PA; Sagna T; Nébié I; Guira O; Tiéno H; Drabo YJ
    Med Sante Trop; 2014; 24(3):307-11. PubMed ID: 25296130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characteristics of the patients "lost to follow-up" and determining factors of loss to follow-up to patients living with HIV at Ouagadougou, Burkina Faso].
    Bognounou R; Kabore M; Diendéré A; Diallo I; Sagna Y; Guira O; Tieno H; Ouedraogo DD; Drabo YJ
    Bull Soc Pathol Exot; 2015 Aug; 108(3):197-200. PubMed ID: 26141498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determinants of low birth weight among newborns to HIV-infected mothers not eligible for antiretroviral treatment in Africa].
    Traore H; Meda N; Nagot N; Somé E; Neboua D; Kankasa C; Hofmeyr J; Tumwine J; Vallo R; Ye D; Tylleskar T; Van de Perre P
    Rev Epidemiol Sante Publique; 2013 Oct; 61(5):413-20. PubMed ID: 24016738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Features of Metabolic Syndrome and Its Associated Factors during Highly Active Antiretroviral Therapy in Ouagadougou (Burkina Faso).
    Guira O; Tiéno H; Diendéré AE; Sagna Y; Diallo I; Yaméogo B; Zoungrana L; Yaméogo TM; Bognounou R; Drabo JY
    J Int Assoc Provid AIDS Care; 2016; 15(2):159-63. PubMed ID: 26307211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Failure of first-line antiretroviral therapy in HIV-infected children in Ouagadougou, Burkina Faso].
    Kouéta F; Yé D; Zoungrana A; Sacko A; Ouédraogo-Traoré R; Kafando E; Ouédraogo S
    Med Trop (Mars); 2010 Dec; 70(5-6):517-23. PubMed ID: 21520658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicoepidemiological characteristics of HIV-infected immigrants attended at a tropical medicine referral unit.
    Pérez-Molina JA; López-Vélez R; Navarro M; Pérez-Elías MJ; Moreno S
    J Travel Med; 2009; 16(4):248-52. PubMed ID: 19674264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of maternal HAART on the prevention of mother-to-child transmission of HIV: results of an 18-month follow-up study in Ouagadougou, Burkina Faso.
    Kouanda S; Tougri H; Cisse M; Simpore J; Pietra V; Doulougou B; Ouedraogo G; Ouedraogo CM; Soudre R; Sondo B
    AIDS Care; 2010 Jul; 22(7):843-50. PubMed ID: 20635248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Modalities of Nonadherence to Highly Active Antiretroviral Therapy and the Associated Factors Related to Patients' Sociodemographic Characteristics and Their Caregiving Perceptions in Ouagadougou (Burkina Faso).
    Guira O; Kaboré DS; Dao G; Zagré N; Zohoncon TM; Pietra V; Drabo JY; Simporé J
    J Int Assoc Provid AIDS Care; 2016 May; 15(3):256-60. PubMed ID: 26567225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Is ovarian function impaired in HIV patients? A clinical pilot study in Burkina Faso].
    Willems N; Lemoine C; Liesnard C; Gervy C; Hien AD; Karama R; Somda I; Englert Y
    Rev Med Brux; 2013; 34(5):397-404. PubMed ID: 24303653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Haematological parameters evolution during the antiretroviral therapy of HIV infected patients in Burkina-Faso].
    Nacoulma EW; Some Y; Tieno H; Diallo I; Zoungrana A; Bougnounou R; Ouédraogo C; Drabo J; Guiard-Schmid JB
    Bull Soc Pathol Exot; 2007 Oct; 100(4):271-4. PubMed ID: 17982857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. User fees and access to ARV treatment for persons living with HIV/AIDS: implementation and challenges in Burkina Faso, a limited-resource country.
    Kouanda S; Bocoum FY; Doulougou B; Bila B; Yameogo M; Sanou MJ; Sawadogo M; Sondo B; Msellati P; Desclaux A
    AIDS Care; 2010 Sep; 22(9):1146-52. PubMed ID: 20824567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretroviral treatment and quality of life in Africans living with HIV: 12-month follow-up in Burkina Faso.
    Jaquet A; Garanet F; Balestre E; Ekouevi DK; Azani JC; Bognounou R; Dah E; Kondombo JC; Dabis F; Drabo J
    J Int AIDS Soc; 2013 Dec; 16(1):18867. PubMed ID: 24369739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surveillance of transmitted drug-resistant HIV among young pregnant women in Ouagadougou, Burkina Faso.
    Somda A; Sangare L; Soro M; Yameogo S; Bazie B; Bigirimana F; Bertagnolio S; Peeters M; Mouacha F; Rivera AM; Jordan MR; Sanou MJ
    Clin Infect Dis; 2012 May; 54 Suppl 4(Suppl 4):S317-9. PubMed ID: 22544195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreasing incidence of cryptococcal meningitis in West Africa in the era of highly active antiretroviral therapy.
    Bamba S; Lortholary O; Sawadogo A; Millogo A; Guiguemdé RT; Bretagne S
    AIDS; 2012 May; 26(8):1039-41. PubMed ID: 22552479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of drug-resistance mutations in HIV-1 isolates from non-HAART and HAART treated patients in Burkina Faso.
    Nadembega WM; Giannella S; Simpore J; Ceccherini-Silberstein F; Pietra V; Bertoli A; Pignatelli S; Bellocchi MC; Nikiema JB; Cappelli G; Bere A; Colizzi V; Perno CP; Musumeci S
    J Med Virol; 2006 Nov; 78(11):1385-91. PubMed ID: 16998878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.